Skip to main content

High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates

European Journal of Clinical Microbiology and Infectious Diseases volume 22, pages 603–607 (2003)Cite this article

Abstract

High-dose (5–7 mg/kg/day) liposomal amphotericin B was evaluated prospectively during the period 1995–2001 in 41 episodes of systemic candidiasis occurring in 37 neonates (36 of the 37 were premature infants with very low birth weights). Median age at the onset of systemic candidiasis was 17 days. Candida spp. were isolated from blood in all patients and from urine, skin abscesses and peritoneal fluid in 6, 5 and 1 neonates, respectively. Candidiasis was due to Candida parapsilosis in 17 cases, Candida albicans in 15 cases, Candida tropicalis in 5 cases, Candida guilliermondii in 2 cases, Candida glabrata in 2 cases and an unidentified Candida sp. in 1 case. Twenty-eight, five and eight infants received 7, 6–6.5 and 5 mg/kg/day, respectively. Median duration of therapy was 18 days; median cumulative dose was 94 mg/kg. Fungal eradication was achieved in 39 of 41 (95%) episodes; median duration of therapy until fungal eradication was 8.7±4.5 days. Fungal eradication was achieved after 10.9±4.8 days in patients who had received previous antifungal therapy compared to 8.2±4.3 days in those treated with liposomal amphotericin B as first-line therapy. One patient died due to systemic candidiasis on day 12 of therapy. High-dose liposomal amphotericin B was effective and safe in the treatment of neonatal candidiasis. Fungal eradication was more rapid in patients treated early with high doses and in patients who received high-dose liposomal amphotericin B as first-line therapy.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. van den Anker JN, van Popele NM, Sauer PJJ (1995) Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother 39:1391–1397

    PubMed  Google Scholar 

  2. Rowen JL, Tate JM (1998) Management of neonatal candidiasis. Pediatr Infect Dis J 17:1007–1011

    Article  CAS  PubMed  Google Scholar 

  3. Deray G (2002). Amphotericin B nephrotoxicity. J Antimicrob Chemother 49 [Suppl S1]:37–41

  4. Baley JE, Kliegman RM, Fanaroff AA (1984) Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity. Pediatrics 73:153–157

    CAS  PubMed  Google Scholar 

  5. Koren G, Lau A, Klein J, Golas C, Bologna-Campeanu M, Soldin S, MacLeod SM, Prober C (1988) Pharmacokinetics and adverse events of amphotericin B in infants and children. J Pediatr 113:559–563

    CAS  PubMed  Google Scholar 

  6. Kingo ARM, Smyth JA, Waisman D (1997) Lack of evidence of amphotericin toxicity in very low birth weight infants treated for systemic candidiasis. Pediatr Infect Dis J 16:1002–1003

    Article  CAS  PubMed  Google Scholar 

  7. Kossoff EH, Buescher ES, Karlowicz MG (1998) Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 17:504–508

    CAS  PubMed  Google Scholar 

  8. Friedman S, Richardson SE, Jacobs SE, O'Brien K (2000) Systemic Candida infection in extremely low birth weight infants: short-term morbidity and long-term neurodevelopmental outcome. Pediatr Infect Dis J 19:499–504

    Article  CAS  PubMed  Google Scholar 

  9. Huttova M, Hartmanova I, Kralinsky K, Filka J, Uher J, Kurak J, Krizan S, Krcmery V Jr (1998) Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Pediatr Infect Dis J 17:1012–1015

    Article  CAS  PubMed  Google Scholar 

  10. Huang YC, Lin TY, Lien RI, Chou YH, Kuo CY, Yang PH, Hsieh WS (2000) Fluconazole therapy in neonatal candidemia. Am J Perinatol 17:411–415

    Article  CAS  PubMed  Google Scholar 

  11. Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, Hiemenz J, Chanock SJ (1999) Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J 18:702–708

    Article  CAS  PubMed  Google Scholar 

  12. Adler-Shohat F, Waskin H, Lieberman JM (2001) Amphotericin B lipid complex for neonatal invasive candidiasis. Arch Dis Child Fetal Neonatal Ed 84:F131–133

    PubMed  Google Scholar 

  13. Hann IM, Prentice HG (2001) Lipid-based amphotericin B: a review of the last 10 years of use. Int J Antimicrob Agents 17:161–169

    Article  CAS  PubMed  Google Scholar 

  14. Lackner H, Schwinger W, Urban C, Muller W, Ritschl E, Reiterer F, Kutttnig-Haim M, Urlesberger B, Hauer C (1992) Liposomal amphotericin B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics 89:1259–1261

    CAS  PubMed  Google Scholar 

  15. Adler-Moore JP, Proffitt RT (1993) Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J Liposome Res 3:429–450

    CAS  Google Scholar 

  16. Jarlov JO, Born P, Bruun B (1995) Candida albicans meningitis in a 27 weeks premature infant treated with liposomal amphotericin B (AmBisome). Scand J Infect Dis 27:419–420

    CAS  PubMed  Google Scholar 

  17. Evdoridou J, Roilides E, Bibashi E, Kremenoupoulos G (1997) Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review. Infection 25:112–116

    CAS  PubMed  Google Scholar 

  18. Al Arishi H, Frayha HH, Kalloghlian A, Alaiyan SA (1997) Liposomal amphotericin B in neonates with invasive candidiasis. Am J Perinatol 14:573–576

    PubMed  Google Scholar 

  19. Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A (1998) Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J 17:146–148

    Article  CAS  PubMed  Google Scholar 

  20. Weitkamp JH, Poets CF, Sievers R, Musswessels E, Groneck P, Thomas P, Bartmann P (1998) Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome). Infection 26:11–15

    CAS  PubMed  Google Scholar 

  21. Juster-Reicher A, Leibovitz E, Linder N, Amitay M, Flidel-Rimon O, Even-Tov S, Mogilner B, Barzilai A (2000) Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants. Infection 28:223–226

    Article  CAS  PubMed  Google Scholar 

  22. Russo R, Nigro LC, Minniti S, Montineri A, Gradoni L, Caldeira L, Davidson RN (1996) Visceral leishmaniasis in HIV-infected patients: treatment with high-dose liposomal amphotericin B (AmBisome). J Infect 32:133–137

    CAS  PubMed  Google Scholar 

  23. Thakur CP (2001) A single high-dose treatment of kala-azar with AmBisome (amphotericin B lipid complex): a pilot study. Int J Antimicrob Agents 17:67–70

    Article  CAS  PubMed  Google Scholar 

  24. Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie E (2001) Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother 45:3487–3496

    Article  CAS  PubMed  Google Scholar 

  25. Chapman RL, Faix RG (2000) Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J 19:822–827

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Neonatology, Kaplan Medical Center, 76100, Rehovot, Israel

    A. Juster-Reicher, O. Flidel-Rimon, M. Amitay, S. Even-Tov & E. Shinwell

  2. Pediatric Infectious Disease Unit, Soroka University Medical Center, PO Box 151, 84101, Beer-Sheva, Israel

    E. Leibovitz

Authors
  1. A. Juster-Reicher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Flidel-Rimon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Amitay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Even-Tov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Shinwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Leibovitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Leibovitz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Juster-Reicher, A., Flidel-Rimon, O., Amitay, M. et al. High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates. Eur J Clin Microbiol Infect Dis 22, 603–607 (2003). https://doi.org/10.1007/s10096-003-0993-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-003-0993-4

Keywords

  • Candidiasis
  • Visceral Leishmaniasis
  • Liposomal Amphotericin
  • Candida Tropicalis
  • Candida Glabrata